News Focus
News Focus
icon url

DewDiligence

11/19/10 12:55 PM

#109265 RE: Mpower #109263

Apixaban’s failure in ACS barely affects Lovenox, which derives only a tiny proportion of its sales in ACS. Where Apixaban’s failure in ACS affects MNTA is in boosting the prospects for M118.